Jun 30, 2013

United Therapeutics Q2 2013 Earnings Report

Total Revenue
$281M
Previous year: $226M
+24.4%
EPS
$3.11
Previous year: $2.37
+31.2%
Gross Profit
$248M
Previous year: $196M
+26.7%
Cash and Equivalents
$344M
Previous year: $157M
+118.8%
Total Assets
$1.78B
Previous year: $1.56B
+14.2%

United Therapeutics

United Therapeutics